NIH NIAID Chemical Countermeasures Research Program (CCRP)
The NIH NIAID Chemical Countermeasures Research Program (CCRP) is part of the civilian biodefense research effort within the Department of Health and Human Services (HHS) and NIH. The goal of CCRP is to integrate cutting-edge research with the latest advances in science and medicine to enhance the nation’s medical response capabilities during chemical-related public health emergencies. The CCRP is particularly interested in supporting the research and development of medical countermeasures specifically for chemically-induced pulmonary injuries.
Current funding opportunities include:
- PAR-18-657: CounterACT Research Centers of Excellence (U54 Clinical Trial Optional)
- PAR-18-721: CounterACT Exploratory/Developmental Projects in Translational Research (R21 Clinical Trial Not Allowed)
- PAR-19-039: CounterACT Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
- PAR-19-040: CounterACT Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Investigators should contact the CCRP office at 301-451-4416 or reach out directly to Gennady E. Platoff Jr, PhD, Dave Yeung, PhD, or David A. Jett, PhD for more information.
Join the 11th Annual ATS Foundation Research Program Benefit
The ATS will honor Sharon Rounds, MD, with the 2019 Breathing for Life Award at the 11th Annual ATS Foundation Research Program Benefit. This is the highest honor awarded by the Foundation. Please join us to recognize Dr. Rounds’ philanthropy, scientific achievement, and commitment to mentorship.
The ATS Foundation would like to acknowledge Genentech and GSK for their Sapphire Level Support of the 11th Annual ATS Foundation Research Program Benefit.
Where: Union Station in Dallas, Texas
When: 7 p.m., Sat., May 18, 2019
You can also honor Dr. Rounds by donating to the Research Program.
ATS 2019 attendees who donate $100.00 to the Research Program at the ATS Center during the conference will receive their own ATS-branded lungs, while supplies last! Donors will also be recognized on the ATS Instagram account.
Where: Exhibit Hall (Hall D), booth #2726
When: 10:30 a.m. – 3:30 p.m., Sun., May 19, 2019 to Tues., May 21, 2019
ATS Foundation Research Program Grants – Apply Now!
Last year, the ATS Foundation awarded 30 grants totaling $1.6 million. The 2019 cycle is now open, and 15 unrestricted grants are available, including one grant specific to nurses.
Deadline to submit an LOI is June 17, 2019.
Hermansky-Pudlak Syndrome Patient Education Day
As part of “Hermansky-Pudlak Syndrome Week at the ATS” and in conjunction with PAR partner the Hermansky-Pudlak Syndrome Network, the San Juan City Hospital, and the Mayaguez Medical Center Pulmonary Fibrosis Clinic, the American Thoracic Society is hosting a Hermansky-Pudlak Syndrome Patient Education Day.
When: 9 a.m. – 4 p.m., Sat., April 27, 2019
Where: Isla Verde Marriott in San Juan, Puerto Rico, and online. Please note that some sessions will be in Spanish.
Don’t Miss the Best in Sleep and Respiratory Neurobiology
As the understanding of sleep disorders continues to evolve, so does innovative sleep research. At ATS 2019, you’ll have access to presentations and discussions covering cutting-edge sleep research.
Highlights include:
